ARCHIVES

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

This article is from The Cancer Letter archive.

Vol. 24 No. 16 | April 24, 1998

Download PDF Visit The Full Archive

Related Articles

News Council Says Post Series “Flawed By Sensationalism”

June 11, 1982

Final Count On Funded CCOPs Probably Delayed for Months; Many To Continue Without NCI Money

April 24, 1987

NCI Cooperative Group Clinical Trials Approved

January 29, 2010

LeMaistre To Retire As M.D. Anderson President In 1996

August 18, 1995

CMS To Begin National Coverage Analysis Of Provenge

July 2, 2010

Study Attributes Drop In Breast Cancer Incidence To Decline In Hormone Replacement.

December 15, 2006